Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.404 Factor de Impacto de 5 años: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v28.i3.40
pages 229-248

Endothelial Injury, Alarmins, and Allog raft Rejection

Deepak A. Rao
Department of Immunobiology, Section of Human and Translational Immunology, Yale University School of Medicine, New Haven, CT 06520-8089
Jordan S. Pober
Department of Immunobiology, Section of Human and Translational Immunology, Yale University School of Medicine, New Haven, CT 06520-8089


Allograft blood vessels are important targets of clinical allograft rejection. Perioperative allograft injury to graft vasculature, especially the endothelial ñåll (EC) lining, increases the risk of subsequent acute and chronic vascular rejection. We hypothesize that allograft EC injured by ischemia-reperfusion (I/R) during transplantation releases mediators, termed “alarmins,” that alter and intensify the host antigraft adaptive immune response. We begin with a review of both perioperative I/R injury to graft endothelium and T-cell-mediated vascular rejection. We then describe several alarmins that may be released from injured allografts, including interleukin (IL)-1α, ATP, monosodium urate (MSU), and high mobility group protein B1 (HMGB1). These mediators have in common the ability to induce production of IL-1 β from mononuclear phagocytes, and both isoforms of IL-1 act on T cells to enhance destructive adaptive immune responses. Therefore, we propose that IL-1 is the key alarmin that communicates graft injury to the host's adaptive immune system, and we suggest that perioperative targeting of IL-1 represents a promising strategy to attenuate the strength of rejection reactions.

Articles with similar content:

Role of Innate Immunity in Transplantation Tolerance
Critical Reviews™ in Immunology, Vol.28, 2008, issue 5
Dale L. Greiner, Aldo A. Rossini, David M. Miller
Infectious Tolerance as Candidate Therapy for Type 1 Diabetes: Transfer of Immunoregulatory Properties from Human Regulatory T Cells to Other T Cells and Proinflammatory Dendritic Cells
Critical Reviews™ in Immunology, Vol.33, 2013, issue 5
Bart O. Roep, Fleur S. Kleijwegt
Regulation of Dendritic- and T-Cell Fate by Injury-Associated Endogenous Signals
Critical Reviews™ in Immunology, Vol.29, 2009, issue 1
Marco E. Bianchi, Annalisa Capobianco, Angelo A. Manfredi, Patrizia Rovere-Querini
Improving Immunotherapy by Conditionally Enhancing MHC Class I Presentation of Tumor Antigen-Derived Peptide Epitopes
Critical Reviews™ in Immunology, Vol.27, 2007, issue 5
Ronald M. Bukowski, Mayumi Kawabe, Peter A. Cohen, James H. Finke, Amy K. Wesa, Walter J. Storkus, Christopher Herrem
Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System
Critical Reviews™ in Immunology, Vol.17, 1997, issue 1
Thierry Calandra , Richard Bucala